Preoperative chemoradiotherapy versus preoperative radiotherapy in rectal cancer patients: assessment of acute toxicity and treatment compliance. Report of the 22921 randomised trial conducted by the EORTC Radiotherapy Group.

Bosset, J F; Calais, G; Daban, A; Berger, C; Radosevic-Jelic, L; Maingon, P; Bardet, E; Pierart, M; Briffaux, A

Bosset, J F; Calais, G; Daban, A; Berger, C; Radosevic-Jelic, L; Maingon, P; Bardet, E; Pierart, M; Briffaux, A.

Affiliation

Bosset JF; Besançon University Hospital, Boulevard Fleming, F-25030, Besancon Cedex, France. jean-francois.bosset@ufc-chu.univ-fcomte.fr

Eur J Cancer ; 40(2): 219-24, 2004 Jan.

Article in En | MEDLINE | ID: mdl-14728936

Subject(s)

Antineoplastic Combined Chemotherapy Protocols/adverse effects; Rectal Neoplasms/drug therapy; Rectal Neoplasms/radiotherapy; Adult; Aged; Combined Modality Therapy; Female; Fluorouracil/administration & dosage; Humans; Leucovorin/administration & dosage; Male; Middle Aged; Patient Compliance; Prognosis; Radiotherapy Dosage; Rectal Neoplasms/surgery

Search on Google

XML

PubMed Links

Database: MEDLINE Main subject: Rectal Neoplasms / Antineoplastic Combined Chemotherapy Protocols Type of study: Clinical_trials / Guideline / Prognostic_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Year: 2004 Type: Article

Search on Google

XML

PubMed Links